Literature DB >> 2722186

Genetic studies of human apolipoproteins. VIII. Role of the apolipoprotein H polymorphism in relation to serum lipoprotein concentrations.

B Sepehrnia1, M I Kamboh, L L Adams-Campbell, C H Bunker, M Nwankwo, P P Majumder, R E Ferrell.   

Abstract

Apolipoprotein H (APO H) has recently been identified as a structural component of chylomicrons, very low-density lipoproteins (VLDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL). Although the precise metabolic function of APO H in lipid metabolism is not certain, it has been suggested that APO H may be involved in triglyceride (TG) metabolism. In addition to the previously described quantitative polymorphism, we have recently detected a common qualitative polymorphism at the APO H structural locus. To test the role of APO H genetic variation in determining lipoprotein and lipid levels, we have estimated the allelic effects of APO H variation on TG, VLDL, LDL, HDL, HDL3, and total cholesterol on 356 Nigerian blacks (189 males, 167 females). While no significant effect of phenotype was observed on lipoprotein levels, the effect of interaction between phenotype and gender was significant. Therefore, data on males and females were analyzed separately using analysis of variance after adjusting for age and body mass index. Logarithmic transformation of pertinent variables was done to bring the distribution of the variables closer to normality. A statistically significant effect of phenotype was observed on triglyceride levels in females only (P less than 0.05). Further analysis of this phenotypic effect revealed that it is due to the impact of the APO H*3 allele, which raises triglycerides by 9.92 mg/dl as compared to the common allele, APO H*2. These findings are in accordance with the postulated role of APO H in triglyceride metabolism. On the basis of its sex-specific effect, we propose a hypothesis that may explain the combined influence of the quantitative and qualitative polymorphisms at the APO H locus on triglyceride levels in females.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2722186     DOI: 10.1007/BF00284041

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  23 in total

1.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.

Authors:  G R Warnick; J J Albers
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

2.  A sensitive immunoblotting technique to identify thyroxin-binding globulin protein heterogeneity after isoelectric focusing.

Authors:  M I Kamboh; R E Ferrell
Journal:  Biochem Genet       Date:  1986-04       Impact factor: 1.890

3.  The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods.

Authors:  E Boerwinkle; R Chakraborty; C F Sing
Journal:  Ann Hum Genet       Date:  1986-05       Impact factor: 1.670

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Quantitative determination of serum triglycerides by the use of enzymes.

Authors:  G Bucolo; H David
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

6.  [Genetic studies on the deficiency of beta 2-glycoprotein I of human serum].

Authors:  H Cleve
Journal:  Humangenetik       Date:  1968

7.  The general relationship between average effect and average excess.

Authors:  A R Templeton
Journal:  Genet Res       Date:  1987-02       Impact factor: 1.588

8.  Binding of beta 2-glycoprotein-I to intralipid: determination of the dissociation constant.

Authors:  E Polz; G M Kostner
Journal:  Biochem Biophys Res Commun       Date:  1979-10-29       Impact factor: 3.575

9.  Assessment of cardiovascular risk factors in Nigerian students.

Authors:  L L Adams-Campbell; M U Nwankwo; J A Omene; F A Ukoli; M P Young; G T Haile; L H Kuller
Journal:  Arteriosclerosis       Date:  1988 Nov-Dec

10.  The relation of sex, smoking status, birth rank, and parental age to beta2-glycoprotein I levels and phenotypes in a sample of Australian Caucasian adults.

Authors:  D N Propert
Journal:  Hum Genet       Date:  1978-09-19       Impact factor: 4.132

View more
  5 in total

1.  Comprehensive evaluation of apolipoprotein H gene (APOH) variation identifies novel associations with measures of lipid metabolism in GENOA.

Authors:  Magalie S Leduc; Lawrence C Shimmin; Kathy L E Klos; Craig Hanis; Eric Boerwinkle; James E Hixson
Journal:  J Lipid Res       Date:  2008-08-01       Impact factor: 5.922

2.  Urinary excretion of beta 2-glycoprotein-1 (apolipoprotein H) and other markers of tubular malfunction in "non-tubular" renal disease.

Authors:  F V Flynn; M Lapsley; P A Sansom; S L Cohen
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

3.  Phospholipid-containing toxic malaria antigens induce hypoglycaemia.

Authors:  K Taylor; C A Bate; R E Carr; G A Butcher; J Taverne; J H Playfair
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

4.  Association of the Trp316Ser variant (rs1801690) near the apolipoprotein H (β2-glycoprotein-I) gene and serum lipid levels.

Authors:  Tao Guo; Rui-Xing Yin; Hui Li; Yi-Ming Wang; Jin-Zhen Wu; De-Zhai Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

5.  Genetic studies of human apolipoproteins. XX. Genetic polymorphism of apolipoprotein J and its impact on quantitative lipid traits in normolipidemic subjects.

Authors:  M I Kamboh; J A Harmony; B Sepehrnia; M Nwankwo; R E Ferrell
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.